Quick Answer
Breastfeeding plans before CAR T-cell therapy should be individualized with the oncology team and the clinicians advising on medicines and infant care. Review every medicine and agree on a written plan for feeding, expressing milk, and caregiver arrangements.
- Tell the oncology team early if you are breastfeeding, expressing milk, or recently weaned.
- Ask an oncology pharmacist or clinician to review every medicine in the treatment plan, including chemotherapy and medicines for symptoms or infection prevention.
- Evidence about some CAR T-cell products and medicines during lactation may be limited, so ask for guidance specific to your treatment and circumstances.
- Confirm in writing whether to nurse, express milk, pause, or stop, and what instructions apply to stored milk and resuming breastfeeding.
- Coordinate the plan with a lactation specialist and your baby’s pediatric clinician, and make sure caregivers can follow the same feeding instructions.
- Plan for possible time away from your infant, hospitalization, or feeling too unwell to provide care, and identify caregivers who can step in.
- Ask whom to contact if medicines, treatment dates, or your baby’s needs change.
What Should Breastfeeding Parents Discuss Before CAR T-Cell Therapy?
Breastfeeding plans before CAR T-cell therapy should be made with your oncology team and reviewed with the clinicians who advise on your medicines and your baby’s care. There is no single pause or stop recommendation that applies to every parent. The plan depends on the exact treatment schedule, the medicines used, your health, and your infant’s needs. Ask for individualized guidance before treatment begins, and do not delay or change cancer treatment based on general information alone.
CAR T-cell therapy uses a patient’s immune cells, which are changed to recognize and attack cancer cells. The treatment process can also involve chemotherapy before the cell infusion, other medicines, monitoring, and sometimes a hospital stay. Each part of that plan may raise different questions about nursing, expressing milk, and who will care for your baby. Available information about some CAR T-cell products and breast milk may be limited, so your team may need to assess each medicine rather than rely on a general rule.
It can be emotionally difficult to weigh feeding plans alongside urgent cancer care. You deserve clear, nonjudgmental answers and practical support, whether you hope to continue breastfeeding, pause temporarily, or stop. Write down your questions and request a shared plan that includes treatment dates, medication-specific instructions, infant feeding arrangements, and whom to contact if circumstances change. If you receive care away from home, ask how your teams will communicate across locations and languages.
Get expert support for your treatment
Let our coordination team prepare a personalized plan for you.
Contact information
Your information is only used to contact you and is never shared with third parties.
Your request has been received!
Your request has been received! Our coordination team will contact you as soon as possible.
Raise breastfeeding before the treatment schedule is finalized
Tell your oncology team that you are breastfeeding, expressing milk, or recently weaned as early as possible. This information can help the team review the full treatment plan and arrange advice from an oncology pharmacist, lactation specialist, and your baby’s pediatric clinician. You do not need to have decided whether to continue nursing before you bring it up.
CAR T-cell therapy is more than the cell infusion. The overall plan may include preparation, medicines to control symptoms or prevent complications, and monitoring afterward. If you want plain-language background before discussing the details, a resource on what CAR means in CAR T-cell therapy may help you follow the conversation. Your own team should still explain which parts apply to your treatment.
Ask when the team expects to confirm medication choices and whether any changes to the schedule are anticipated. If care involves several facilities or clinicians, find out who will coordinate the advice and keep a current medication list. For international patients, confirm how you can reach the care team across time zones, whether an interpreter is available, and how written instructions can be shared with your local clinicians. Early discussion creates time to organize care without assuming a particular feeding decision is best for you.
Review every medicine, not just the CAR T-cell infusion
Ask an oncology pharmacist or clinician to review each medicine in your plan and explain whether it could affect breast milk or nursing. Include lymphodepleting chemotherapy, which is chemotherapy given before the CAR T-cell infusion to prepare the body for treatment. Also ask about any bridging treatment used while waiting for infusion, as well as medicines for nausea, infection prevention, pain, fever, or other symptoms.
You can bring a written list of current prescriptions, over-the-counter medicines, supplements, and the times you usually feed or express milk. For each treatment medicine, ask: Is there information about use during lactation? Should I pause or stop nursing? If a pause is recommended, what determines its duration and who will tell me when it is safe to resume? Ask the team to distinguish evidence about a specific medicine from uncertainty about the CAR T-cell product itself.
Evidence about some therapies and their presence or effects in breast milk may be limited. That uncertainty does not establish that milk is safe or unsafe. Request advice tied to your exact products, doses, timing, and health circumstances, preferably in writing. If a new medicine is added or the treatment plan changes, check again rather than assuming earlier guidance still applies.
Turn clinical advice into a practical feeding plan
Ask the team to translate medication guidance into steps you can follow. Your plan may need to state whether to nurse, express milk, pause, or stop, and exactly which dates or medicine changes affect that advice. Do not assume that a standard waiting period applies across different medicines or CAR T-cell treatment plans.
If you are advised to express milk during a pause, ask whether it should be discarded or whether any storage is appropriate. Confirm how to label and store milk, and whether milk expressed before treatment can be used for your baby. Do not offer stored milk during a period when your clinicians have advised against breastfeeding or milk use unless they have specifically confirmed it is suitable for your situation.
If you want to maintain milk production, ask a lactation specialist whether expressing is appropriate and how often to do it given your health and treatment schedule. If you prefer or need to stop, seek advice on doing so comfortably and safely. Discuss formula, donor milk where available, or other feeding arrangements with your pediatric clinician. A written plan can help family members and caregivers follow the same instructions, especially if you are away from home or your medicines change.
Prepare caregivers for hospital time and possible side effects
Ask how long you may need to stay near the treatment center and whether hospitalization is planned. The timing and length of monitoring can vary, so make a flexible arrangement for who will feed and care for your infant if you are away or feel too unwell to provide care. Decide who can step in, how they will receive feeding instructions, and how they can contact your clinical team.
CAR T-cell therapy can cause side effects that need prompt clinical attention. Cytokine release syndrome, or CRS, is an inflammatory reaction that can cause symptoms such as fever and may require treatment. Immune effector cell-associated neurotoxicity syndrome, or ICANS, refers to neurological changes that can affect thinking, speech, alertness, or other functions. Ask your team what signs to watch for and who to call, including after leaving the hospital. A guide on when to seek medical help after CAR T-cell therapy can support, but not replace, your team’s specific instructions.
Discuss what should happen if you become confused, very unwell, or need urgent assessment while your infant is with you. Keep caregiver contact details, feeding instructions, and emergency numbers accessible. If you develop a fever or another symptom your team has warned you about, follow its urgent-care instructions rather than trying to manage the situation alone while caring for your baby.
Make sure your oncology, lactation, and pediatric teams agree
A coordinated plan depends on each clinician having the same current information. Ask your oncology team to share the treatment and medication schedule with the pharmacist, lactation specialist, and your infant’s pediatric clinician, with your permission. If your care is split between countries or facilities, clarify who is responsible for answering lactation questions and how updates will be communicated.
Your baby’s age, health, feeding pattern, and any medical needs may affect practical planning. Ask the pediatric clinician what feeding changes to expect, how to monitor your baby’s intake and well-being, and when follow-up is needed. The clinician can also help you plan for transitions if you pause nursing or change feeding methods. These are planning questions, not a reason to delay cancer treatment while waiting for perfect certainty.
Before treatment, confirm whom to contact if a medicine is added, you miss a dose, the infusion date changes, or your baby becomes unwell. Request translated or easy-to-share written instructions if language differences could make handoffs difficult. You might also ask whether a family member or support person can join a discussion, take notes, and help relay the plan. Consistent guidance makes it easier for you and your caregivers to act on the same recommendations.
Frequently Asked Questions
Q: Can I continue breastfeeding during CAR T-cell therapy?
Get expert support for your treatment
Let our coordination team prepare a personalized plan for you.
Contact information
Your information is only used to contact you and is never shared with third parties.
Your request has been received!
Your request has been received! Our coordination team will contact you as soon as possible.
A: Your care team needs to review your specific CAR T-cell plan and every medicine involved before advising you. Available evidence may be limited, so there is no universal recommendation for all parents. Ask your oncology clinician and pharmacist for a written, medicine-specific plan.
Q: Can chemotherapy before CAR T-cell therapy affect breast milk?
A: Some preparation plans include lymphodepleting chemotherapy, and the medicines need individual review for lactation. Ask the pharmacist which medicines are planned and whether nursing or expressed milk should be avoided. Do not rely on a general waiting period.
Q: How long might I need to pause or stop breastfeeding?
A: The timing depends on the medicines used, their schedule, and your clinical circumstances. Your oncology team or pharmacist should explain whether a pause is recommended and what would determine when nursing could resume. Get updated advice if treatment changes.
Q: Can I express and store breast milk before treatment?
A: Ask your team whether expressing milk before treatment is suitable for you and how it should be stored. Confirm whether milk expressed before or during treatment can be used, since instructions may depend on medicine timing. A lactation specialist can help you plan for milk supply or weaning.
Q: Who can help make a feeding plan for my baby?
A: Ask your oncology team to coordinate with an oncology pharmacist, lactation specialist, and your baby’s pediatric clinician. Share the current treatment schedule and medication list with them. Identify one contact for questions if treatment or feeding circumstances change.
The information provided is for educational purposes only and does not constitute medical advice. Always consult with a healthcare professional for medical guidance specific to your situation.
